Halozyme Therapeutics | HALO

Aktienkurs
113.90
Täglich Wechseln
-1.32 -1.15%
Monatlich
6.39%
Jährlich
54.44%
Q3 Prognose
111.44

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-11-09 FY2026Q3 PM 2.18 1.72
2026-08-06 FY2026Q2 PM 2.28 1.81 1.54
2026-05-11 FY2026Q1 PM 1.60 1.76 1.11
2026-02-17 FY2025Q4 PM -0.24 1.9 1.26
2025-11-03 FY2025Q3 PM 1.72 1.59 1.27



Preis Chg Tag Jahr Datum
Acadia Pharmaceuticals 20.68 -1.50 -6.76% -1.76% 2026-09-25
Agios Pharmaceuticals 32.58 -0.32 -0.97% -16.31% 2026-09-25
Alnylam Pharmaceuticals 253.02 -2.94 -1.15% -43.32% 2026-09-28
Amgen 412.24 -2.37 -0.57% 51.01% 2026-09-28
Amarin 13.20 -0.23 -1.71% -17.50% 2026-09-25
Baxter International 23.24 -0.13 -0.56% 5.73% 2026-09-28
Cara Therapeutics 1.27 0.21 19.81% -96.50% 2026-09-25
Cytokinetics 64.66 -1.00 -1.52% 28.29% 2026-09-25
DBV Technologies 11.56 -0.04 -0.34% 26.20% 2026-09-25
Halozyme Therapeutics 113.90 -1.32 -1.15% 54.44% 2026-09-25

Preis Tag Jahr Datum
USND 26936 -132.31 -0.49% 19.80% 2026-09-28
US2000 2815 -22.69 -0.80% 15.59% 2026-09-28